This research article presents a meta-analysis and systematic review investigating the effectiveness of alpha-lipoic acid (ALA) in treating diabetic peripheral neuropathy. The authors synthesize data from randomized controlled trials to determine how this antioxidant affects nerve damage symptoms, such as burning and numbness, alongside metabolic markers like fasting glucose and cholesterol. While the findings suggest that ALA supplementation can reduce certain types of neuropathic pain and improve lipid profiles, it appears to have no significant impact on long-term blood sugar levels measured via HbA1c. The study also catalogues adverse effects, noting that while generally safe, gastrointestinal issues like nausea are common at higher dosages. Ultimately, the researchers conclude that while ALA is a promising complementary therapy, the current evidence is limited by methodological heterogeneity and requires more robust, large-scale studies.